Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Integration of Geriatrician Consultation for Trauma Admissions May Benefit Patient Outcomes.

Saha S, DiRusso SM, Welle S, Lieberman B, Sender J, Shabsigh R, Baltazar GA.

Gerontol Geriatr Med. 2019 Jun 21;5:2333721419858735. doi: 10.1177/2333721419858735. eCollection 2019 Jan-Dec.

2.
3.

Soft-bodied fossils from the upper Valongo Formation (Middle Ordovician: Dapingian-Darriwilian) of northern Portugal.

Kimmig J, Couto H, Leibach WW, Lieberman BS.

Naturwissenschaften. 2019 May 25;106(5-6):27. doi: 10.1007/s00114-019-1623-z.

PMID:
31129730
4.

Circadian-Regulated Cell Death in Cardiovascular Diseases.

Rabinovich-Nikitin I, Lieberman B, Martino TA, Kirshenbaum LA.

Circulation. 2019 Feb 12;139(7):965-980. doi: 10.1161/CIRCULATIONAHA.118.036550.

PMID:
30742538
5.

Cyclophilin D phosphorylation is critical for mitochondrial calcium uniporter regulated permeability transition pore sensitivity.

Dhingra R, Lieberman B, Kirshenbaum LA.

Cardiovasc Res. 2019 Feb 1;115(2):261-263. doi: 10.1093/cvr/cvy270. No abstract available.

PMID:
30380030
6.

Metabolic rates, climate and macroevolution: a case study using Neogene molluscs.

Strotz LC, Saupe EE, Kimmig J, Lieberman BS.

Proc Biol Sci. 2018 Aug 22;285(1885). pii: 20181292. doi: 10.1098/rspb.2018.1292.

PMID:
30135165
7.

Getting somewhere with the Red Queen: chasing a biologically modern definition of the hypothesis.

Strotz LC, Simões M, Girard MG, Breitkreuz L, Kimmig J, Lieberman BS.

Biol Lett. 2018 May;14(5). pii: 20170734. doi: 10.1098/rsbl.2017.0734. Review.

8.

Alanine and glycine conjugates of (2S,4R)-4-[18F]fluoroglutamine for tumor imaging.

Zha Z, Ploessl K, Lieberman BP, Wang L, Kung HF.

Nucl Med Biol. 2018 May;60:19-28. doi: 10.1016/j.nucmedbio.2018.02.001. Epub 2018 Feb 13.

PMID:
29525446
9.

Ellagic acid antagonizes Bnip3-mediated mitochondrial injury and necrotic cell death of cardiac myocytes.

Dhingra A, Jayas R, Afshar P, Guberman M, Maddaford G, Gerstein J, Lieberman B, Nepon H, Margulets V, Dhingra R, Kirshenbaum LA.

Free Radic Biol Med. 2017 Nov;112:411-422. doi: 10.1016/j.freeradbiomed.2017.08.010. Epub 2017 Aug 30.

PMID:
28838842
10.

Bacterial infection imaging with [18F]fluoropropyl-trimethoprim.

Sellmyer MA, Lee I, Hou C, Weng CC, Li S, Lieberman BP, Zeng C, Mankoff DA, Mach RH.

Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8372-8377. doi: 10.1073/pnas.1703109114. Epub 2017 Jul 17.

11.

Disc-shaped fossils resembling porpitids or eldonids from the early Cambrian (Series 2: Stage 4) of western USA.

Lieberman BS, Kurkewicz R, Shinogle H, Kimmig J, MacGabhann BA.

PeerJ. 2017 Jun 6;5:e3312. doi: 10.7717/peerj.3312. eCollection 2017.

12.

[18F](2S,4R)4-Fluoroglutamine PET Detects Glutamine Pool Size Changes in Triple-Negative Breast Cancer in Response to Glutaminase Inhibition.

Zhou R, Pantel AR, Li S, Lieberman BP, Ploessl K, Choi H, Blankemeyer E, Lee H, Kung HF, Mach RH, Mankoff DA.

Cancer Res. 2017 Mar 15;77(6):1476-1484. doi: 10.1158/0008-5472.CAN-16-1945. Epub 2017 Feb 15.

13.

Quantitative PET Reporter Gene Imaging with [11C]Trimethoprim.

Sellmyer MA, Lee I, Hou C, Lieberman BP, Zeng C, Mankoff DA, Mach RH.

Mol Ther. 2017 Jan 4;25(1):120-126. doi: 10.1016/j.ymthe.2016.10.018. Epub 2017 Jan 4.

14.

Comparative evaluation of 4 and 6-carbon spacer conformationally flexible tetrahydroisoquinolinyl benzamide analogues for imaging the sigma-2 receptor status of solid tumors.

Lee I, Lieberman BP, Li S, Hou C, Makvandi M, Mach RH.

Nucl Med Biol. 2016 Nov;43(11):721-731. doi: 10.1016/j.nucmedbio.2016.08.001. Epub 2016 Aug 9.

PMID:
27589334
15.

A systematic exploration of the effects of flexibility and basicity on sigma (σ) receptor binding in a series of substituted diamines.

Conroy T, Manohar M, Gong Y, Wilkinson SM, Webster M, Lieberman BP, Banister SD, Reekie TA, Mach RH, Rendina LM, Kassiou M.

Org Biomol Chem. 2016 Oct 4;14(39):9388-9405.

PMID:
27714195
16.

Iodinated benzimidazole PARP radiotracer for evaluating PARP1/2 expression in vitro and in vivo.

Anderson RC, Makvandi M, Xu K, Lieberman BP, Zeng C, Pryma DA, Mach RH.

Nucl Med Biol. 2016 Dec;43(12):752-758. doi: 10.1016/j.nucmedbio.2016.08.007. Epub 2016 Aug 12.

PMID:
27689533
17.

A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy.

Makvandi M, Xu K, Lieberman BP, Anderson RC, Effron SS, Winters HD, Zeng C, McDonald ES, Pryma DA, Greenberg RA, Mach RH.

Cancer Res. 2016 Aug 1;76(15):4516-24. doi: 10.1158/0008-5472.CAN-16-0416. Epub 2016 Jun 3.

18.

[(18)F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancer.

Edmonds CE, Makvandi M, Lieberman BP, Xu K, Zeng C, Li S, Hou C, Lee H, Greenberg RA, Mankoff DA, Mach RH.

Am J Nucl Med Mol Imaging. 2016 Jan 28;6(1):94-101. eCollection 2016.

19.

Correction to 'Macroevolutionary consequences of profound climate change on niche evolution in marine molluscs over the past three million years'.

Saupe EE, Hendricks JR, Portell RW, Dowsett HJ, Haywood A, Hunter SJ, Lieberman BS.

Proc Biol Sci. 2016 Apr 13;283(1828). pii: 20160654. doi: 10.1098/rspb.2016.0654. No abstract available.

20.

The pre-clinical characterization of an alpha-emitting sigma-2 receptor targeted radiotherapeutic.

Makvandi M, Lieberman BP, LeGeyt B, Hou C, Mankoff DA, Mach RH, Pryma DA.

Nucl Med Biol. 2016 Jan;43(1):35-41. doi: 10.1016/j.nucmedbio.2015.10.001. Epub 2015 Oct 22.

PMID:
26702785
21.

The Evolving Theory of Evolutionary Radiations.

Simões M, Breitkreuz L, Alvarado M, Baca S, Cooper JC, Heins L, Herzog K, Lieberman BS.

Trends Ecol Evol. 2016 Jan;31(1):27-34. doi: 10.1016/j.tree.2015.10.007. Epub 2015 Nov 26. Review.

PMID:
26632984
22.

The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancer.

Makvandi M, Tilahun ED, Lieberman BP, Anderson RC, Zeng C, Xu K, Hou C, McDonald ES, Pryma DA, Mach RH.

Biochem Biophys Res Commun. 2015 Nov 27;467(4):1070-5. doi: 10.1016/j.bbrc.2015.09.157. Epub 2015 Oct 9.

23.

Synthesis and evaluation of tetrahydroindazole derivatives as sigma-2 receptor ligands.

Wu ZW, Song SY, Li L, Lu HL, Lieberman B, Huang YS, Mach RH.

Bioorg Med Chem. 2015 Apr 1;23(7):1463-71. doi: 10.1016/j.bmc.2015.02.012. Epub 2015 Feb 16.

PMID:
25752422
24.

Macroevolutionary consequences of profound climate change on niche evolution in marine molluscs over the past three million years.

Saupe EE, Hendricks JR, Portell RW, Dowsett HJ, Haywood A, Hunter SJ, Lieberman BS.

Proc Biol Sci. 2014 Nov 22;281(1795). pii: 20141995. doi: 10.1098/rspb.2014.1995. Erratum in: Proc Biol Sci. 2016 Apr 13;283(1828). pii: 20160654. doi: 10.1098/rspb.2016.0654.

25.

New olenelloid trilobites from the Northwest Territories, Canada.

Gapp IW, Lieberman BS.

Zootaxa. 2014 Sep 25;3866(4):479-98. doi: 10.11646/zootaxa.3866.4.2.

PMID:
25283671
26.

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

Wu Z, Zha Z, Li G, Lieberman BP, Choi SR, Ploessl K, Kung HF.

Mol Pharm. 2014 Nov 3;11(11):3852-66. doi: 10.1021/mp500236y. Epub 2014 Aug 11.

27.

What is punctuated equilibrium? What is macroevolution? A response to Pennell et al.

Lieberman BS, Eldredge N.

Trends Ecol Evol. 2014 Apr;29(4):185-6. doi: 10.1016/j.tree.2014.02.005. Epub 2014 Mar 11. No abstract available.

PMID:
24629719
28.

Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging.

Wang L, Lieberman BP, Ploessl K, Kung HF.

Nucl Med Biol. 2014 Jan;41(1):58-67. doi: 10.1016/j.nucmedbio.2013.09.011. Epub 2013 Oct 9.

29.

Characterization of FlipIDAM as a SERT-selective SPECT imaging agent.

Lemoine L, Lieberman BP, Ploessl K, Zheng P, Kung HF.

Nucl Med Biol. 2013 Oct;40(7):879-86. doi: 10.1016/j.nucmedbio.2013.06.001. Epub 2013 Jul 12.

PMID:
23856117
30.

High burden and unmet patient needs in chronic kidney disease.

Braun L, Sood V, Hogue S, Lieberman B, Copley-Merriman C.

Int J Nephrol Renovasc Dis. 2012;5:151-63. doi: 10.2147/IJNRD.S37766. Epub 2012 Dec 13.

31.

A new single-photon emission computed tomography (SPECT) imaging agent for serotonin transporters: [(125)I]Flip-IDAM, (2-((2-((dimethylamino)methyl)-4-iodophenyl)thio)phenyl)methanol.

Zheng P, Lieberman BP, Ploessl K, Lemoine L, Miller S, Kung HF.

Bioorg Med Chem Lett. 2013 Feb 1;23(3):869-72. doi: 10.1016/j.bmcl.2012.11.043. Epub 2012 Dec 2.

PMID:
23265880
32.

Unraveling the phylogenetic relationships of the Eccoptochilinae, an enigmatic array of ordovician cheirurid trilobites.

Gapp IW, Congreve CR, Lieberman BS.

PLoS One. 2012;7(11):e49115. doi: 10.1371/journal.pone.0049115. Epub 2012 Nov 16.

33.

Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents.

Ploessl K, Wang L, Lieberman BP, Qu W, Kung HF.

J Nucl Med. 2012 Oct;53(10):1616-24. doi: 10.2967/jnumed.111.101279. Epub 2012 Aug 30.

34.

Function of ovarian tissue after long-term storage.

Lieberman B.

Reprod Biomed Online. 2012 Aug;25(2):96-7. doi: 10.1016/j.rbmo.2012.06.007.

PMID:
22858255
35.

Imaging of VMAT2 binding sites in the brain by (18)F-AV-133: the effect of a pseudo-carrier.

Zhu L, Qiao H, Lieberman BP, Wu J, Liu Y, Pan Z, Ploessl K, Choi SR, Chan P, Kung HF.

Nucl Med Biol. 2012 Oct;39(7):897-904. doi: 10.1016/j.nucmedbio.2012.05.002. Epub 2012 Jun 28.

PMID:
22749185
36.

Synthesis and evaluation of novel tropane derivatives as potential PET imaging agents for the dopamine transporter.

Qiao H, Zhu L, Lieberman BP, Zha Z, Plössl K, Kung HF.

Bioorg Med Chem Lett. 2012 Jul 1;22(13):4303-6. doi: 10.1016/j.bmcl.2012.05.030. Epub 2012 May 15.

37.

Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agents.

Wang L, Zha Z, Qu W, Qiao H, Lieberman BP, Plössl K, Kung HF.

Nucl Med Biol. 2012 Oct;39(7):933-43. doi: 10.1016/j.nucmedbio.2012.03.007. Epub 2012 Apr 26.

38.

Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors.

Qu W, Oya S, Lieberman BP, Ploessl K, Wang L, Wise DR, Divgi CR, Chodosh LA, Thompson CB, Kung HF.

J Nucl Med. 2012 Jan;53(1):98-105. doi: 10.2967/jnumed.111.093831. Epub 2011 Dec 15. Erratum in: J Nucl Med. 2012 Apr;53(4):646. Chodosh, Lewis P [corrected to Chodosh, Lewis A].

39.

PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.

Lieberman BP, Ploessl K, Wang L, Qu W, Zha Z, Wise DR, Chodosh LA, Belka G, Thompson CB, Kung HF.

J Nucl Med. 2011 Dec;52(12):1947-55. doi: 10.2967/jnumed.111.093815. Epub 2011 Nov 15.

40.

Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA).

Zha Z, Choi SR, Ploessl K, Lieberman BP, Qu W, Hefti F, Mintun M, Skovronsky D, Kung HF.

J Med Chem. 2011 Dec 8;54(23):8085-98. doi: 10.1021/jm2009106. Epub 2011 Nov 9.

41.

Phylogenetic and biogeographic analysis of sphaerexochine trilobites.

Congreve CR, Lieberman BS.

PLoS One. 2011;6(6):e21304. doi: 10.1371/journal.pone.0021304. Epub 2011 Jun 27.

42.

Facile synthesis [5-(13)C-4-(2)H(2)]-L-glutamine for hyperpolarized MRS imaging of cancer cell metabolism.

Qu W, Zha Z, Lieberman BP, Mancuso A, Stetz M, Rizzi R, Ploessl K, Wise D, Thompson C, Kung HF.

Acad Radiol. 2011 Aug;18(8):932-9. doi: 10.1016/j.acra.2011.05.002. Epub 2011 Jun 11.

PMID:
21658976
43.

Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands.

Zheng P, Lieberman BP, Choi SR, Plöessl K, Kung HF.

Bioorg Med Chem Lett. 2011 Jun 1;21(11):3435-8. doi: 10.1016/j.bmcl.2011.03.113. Epub 2011 Apr 5.

PMID:
21531556
44.

Synthesis and comparative biological evaluation of L- and D-isomers of 18F-labeled fluoroalkyl phenylalanine derivatives as tumor imaging agents.

Wang L, Lieberman BP, Plössl K, Qu W, Kung HF.

Nucl Med Biol. 2011 Apr;38(3):301-12. doi: 10.1016/j.nucmedbio.2010.10.004. Epub 2010 Dec 3.

PMID:
21492778
45.

Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.

Liu J, Zhu L, Plössl K, Lieberman BP, Kung HF.

Bioorg Med Chem Lett. 2011 May 15;21(10):2962-5. doi: 10.1016/j.bmcl.2011.03.051. Epub 2011 Mar 21.

46.

New F-18 prosthetic group via oxime coupling.

Carberry P, Lieberman BP, Ploessl K, Choi SR, Haase DN, Kung HF.

Bioconjug Chem. 2011 Apr 20;22(4):642-53. doi: 10.1021/bc1004262. Epub 2011 Mar 31.

47.

Oral electrical burns in children-a model of multidisciplinary care.

Yeroshalmi F, Sidoti EJ Jr, Adamo AK, Lieberman BL, Badner VM.

J Burn Care Res. 2011 Mar-Apr;32(2):e25-30. doi: 10.1097/BCR.0b013e31820ab393. Review.

PMID:
21228706
48.

Synthesis, uptake mechanism characterization and biological evaluation of (18)F labeled fluoroalkyl phenylalanine analogs as potential PET imaging agents.

Wang L, Qu W, Lieberman BP, Plössl K, Kung HF.

Nucl Med Biol. 2011 Jan;38(1):53-62. doi: 10.1016/j.nucmedbio.2010.07.005.

49.

Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors.

Qu W, Zha Z, Ploessl K, Lieberman BP, Zhu L, Wise DR, Thompson CB, Kung HF.

J Am Chem Soc. 2011 Feb 2;133(4):1122-33. doi: 10.1021/ja109203d. Epub 2010 Dec 29.

PMID:
21190335
50.

Reducing the incidence of twins from IVF treatments: predictive modelling from a retrospective cohort.

Roberts SA, McGowan L, Mark Hirst W, Vail A, Rutherford A, Lieberman BA, Brison DR; towardSET Collaboration.

Hum Reprod. 2011 Mar;26(3):569-75. doi: 10.1093/humrep/deq352. Epub 2010 Dec 16.

PMID:
21163856

Supplemental Content

Loading ...
Support Center